Yeasts in nanotechnology-enabled oral vaccine and gene delivery

References

• Gavhane YN, Yadav AV. Loss of orally administered drugs in GI tract. Saudi Pharm J. 2012;20:331–344.
   PubMed Web of Science ®Google Scholar
• Hua S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract - influence of physiological, pathophysiological and pharmaceutical factors. Front Pharmacol. 2020;11:524.
   PubMed Web of Science ®Google Scholar
• Vela Ramirez JE, Sharpe LA, Peppas NA. Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev. 2017;114:116–131.
   PubMed Web of Science ®Google Scholar
• Farris E, Sanderfer K, Lampe A, et al. Oral non-viral gene delivery for applications in DNA vaccination and gene therapy. Curr Opin Biomed Eng. 2018;7:51–57.
   PubMedGoogle Scholar
• Holford NHJB. pharmacology c. Pharmacokinetics & pharmacodynamics: rational dosing & the time course of drug action. In: Katzung, BG, Trevor, AJ, eds. Basic & Clinical Pharmacology. 13th ed. New York, NY: McGraw Hill Education
   Google Scholar
• Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10:787–796.
   PubMed Web of Science ®Google Scholar
• Ramamoorth M, Narvekar A. Non viral vectors in gene therapy- an overview. J Clin Diagn Res. 2015;9:GE01–GE6.
   PubMed Web of Science ®Google Scholar
• Uherek C, Wels W. DNA-carrier proteins for targeted gene delivery. Adv Drug Deliv Rev. 2000;44:153–166.
   PubMed Web of Science ®Google Scholar
• Wadhwa A, Aljabbari A, Lokras A, et al. Opportunities and challenges in the delivery of mRNA-based vaccines. Pharmaceutics. 2020;12:102.
   PubMed Web of Science ®Google Scholar
• Yao J, Fan Y, Li Y, et al. Strategies on the nuclear-targeted delivery of genes. J Drug Target. 2013;21:926–939.
   PubMed Web of Science ®Google Scholar
• Neilson S, Dunn A, Bendix A. Moderna’s groundbreaking coronavirus vaccine was designed in just 2 days. Business Insider; 2020.
   Google Scholar
• Coffey JW, Gaiha GD, Traverso G. Oral biologic delivery: advances toward oral subunit, DNA, and mRNA vaccines and the potential for mass vaccination during pandemics. Annu Rev Pharmacol Toxicol. 2021;61:517–540.
   PubMed Web of Science ®Google Scholar
• Sabu C, Mufeedha P, Pramod K. Yeast-inspired drug delivery: biotechnology meets bioengineering and synthetic biology. Expert Opin Drug Deliv. 2019;16:27–41.
   PubMed Web of Science ®Google Scholar
• Risson E. Inactivated vaccine for SARS-CoV-2. Nat Rev Immunol. 2020;20:353.
   PubMed Web of Science ®Google Scholar
• Minor PD. Live attenuated vaccines: historical successes and current challenges. Virology. 2015;479-480:379–392.
   PubMed Web of Science ®Google Scholar
• Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261–279.
   PubMed Web of Science ®Google Scholar
• Liu MA. DNA vaccines: a review. J Inter Med. 2003;253:402–410.
   Google Scholar
• Pollet J, Chen W-H, Strych U. JAddr Recombinant protein vaccines, a proven approach against coronavirus pandemics. Adv Drug Deliv Rev. 2021.
   Google Scholar
• Joshi VS, Bajaj IB, Survase SA, et al. Meningococcal polysaccharide vaccines: a review. Carbohydrate Polymers. 2009;75:553–565.
   Google Scholar
• Rappuoli R, De Gregorio E, Costantino PJ. On the mechanisms of conjugate vaccines. Proc Natl Acad Sci U S A. 2019;116:14–16.
   Google Scholar
• Kitchin NR. Review of diphtheria, tetanus and pertussis vaccines in clinical development. Expert Rev Vaccines. 2011;10:605–615.
   Google Scholar
• Ura T, Okuda K, Shimada MJV. Developments in viral vector-based vaccines. Vaccines (Basel). 2014;2:624–641.
   Google Scholar
• Bergerot I, Ploix C, Petersen J, et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. 1997;94:4610–4614.
   Google Scholar
• Cho HS, Seo JY, Park SI, et al. Oral immunization with recombinant protein antigen expressed in tobacco against fish nervous necrosis virus. Proc Natl Acad Sci U S A. 2018 Feb 20;80(2):272-279.
   Google Scholar
• Huang J, Jia R, Shen H, et al. Oral delivery of a DNA vaccine expressing the PrM and E genes: a promising vaccine strategy against flavivirus in ducks. Sci Rep. 2018;8:1–10.
   Google Scholar
• Plotkin SA, Bouveret-Le Cam N. A new typhoid vaccine composed of the Vi capsular polysaccharide. JAoim. 1995;155:2293–2299.
   Google Scholar
• Quan F-S, Compans RW, Kang S-MJV. Oral vaccination with inactivated influenza vaccine induces cross-protective immunity. Vaccine. 2012;30:180–188.
   Google Scholar
• Sanal MG, Dubey RC. Outcomes. An oral live attenuated vaccine strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV). Research Ideas Outcomes. 2020;6:e53767.
   Google Scholar
• Steel JC, Di Pasquale G, Ramlogan CA, et al. Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer. Mol Ther. 2013;21:680–687.
   Google Scholar
• Lin PY, Chiu YL, Huang JH, et al. Oral nonviral gene delivery for chronic protein replacement therapy. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2018;5:1701079.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Haga K, Ohno I, et al. Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis. BMC Gastroenterol. 2014;14:68.
   PubMed Web of Science ®Google Scholar
• Huang M, Bao J, Nielsen J. Biopharmaceutical protein production bySaccharomyces cerevisiae: current state and future prospects. Pharmaceutical Bioprocessing.2014;2:167–182.
   Google Scholar
• Spohner SC, Schaum V, Quitmann H, et al. Kluyveromyces lactis: an emerging tool in biotechnology. J Biotechnol. 2016;222:104–116.
   PubMed Web of Science ®Google Scholar
• Vieira Gomes AM, Souza Carmo T, Silva Carvalho L, et al. Comparison of yeasts as hosts for recombinant protein production. Microorganisms. 2018;6:38.
   PubMed Web of Science ®Google Scholar
• Zhang T, Sun L, Xin Y, et al. A vaccine grade of yeast Saccharomyces cerevisiae expressing mammalian myostatin. BMC Biotechnol. 2012;12:97.
   PubMed Web of Science ®Google Scholar
• Arnold M, Durairaj V, Mundt E, et al. Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit. PloS One. 2012;7:e42870.
   PubMed Web of Science ®Google Scholar
• Han B, Xu K, Liu Z, et al. Oral yeast-based DNA vaccine confers effective protection from Aeromonas hydrophila infection on Carassius auratus. Fish Shellfish Immunol. 2019;84:948–954.
   PubMed Web of Science ®Google Scholar
• Shin MK, Lee WJ, Jung MH, et al. Oral immunization of mice with Saccharomyces cerevisiae expressing a neutralizing epitope of ApxIIA exotoxin from Actinobacillus pleuropneumoniae induces systemic and mucosal immune responses. Microbiol Immunol. 2013;57:417–425.
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng H, Zhang W, et al. Yeast cell wall particle mediated nanotube-RNA delivery system loaded with miR365 antagomir for post-traumatic osteoarthritis therapy via oral route. Theranostics. 2020;10:8479–8493.
   PubMed Web of Science ®Google Scholar
• Wansley EK, Chakraborty M, Hance KW, et al. Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res. 2008;14:4316–4325.
   Google Scholar
• Cohn A, Morse M, O’Neil B, et al. Treatment of Ras mutation-bearing solid tumors using whole recombinant S. cerevisiae yeast expressing mutated Ras: preliminary safety and immunogenicity results from a phase 1 trial. J Immunother. 2005;23:2571.
   Google Scholar
• Franzusoff A, Duke RC, King TH, et al. Yeasts encoding tumour antigens in cancer immunotherapy. Expert Opin Biol Ther. 2005;5:565–575.
   PubMed Web of Science ®Google Scholar
• Willaert RG. Adhesins of yeasts: protein structure and interactions. J Fungi (Basel). 2018;4:119.
   Google Scholar
• Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev. 2001;50(Suppl 1):S91–101.
   PubMed Web of Science ®Google Scholar
• Sun B, Li ZS, Tu ZX, et al. Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity. World J Gastroenterol. 2006;12:7042–7046.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu X, Chen Y, et al. Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease. Mater Today. 2017;20:301–313.
   Web of Science ®Google Scholar
• Zhou X, Zhang X, Han S, et al. Yeast microcapsule-mediated targeted delivery of diverse nanoparticles for imaging and therapy via the oral route. Nano Lett. 2017;17:1056–1064.
   PubMed Web of Science ®Google Scholar
• Walch B, Breinig T, Schmitt MJ, et al. Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast. Gene Ther. 2012;19:237–245.
   PubMed Web of Science ®Google Scholar
• Pan Y, Li X, Kang T, et al. Efficient delivery of antigen to DCs using yeast-derived microparticles. Sci Rep. 2015;5:10687.
   PubMed Web of Science ®Google Scholar
• Sun Y, Duan B, Chen H, et al. A novel strategy for treating inflammatory bowel disease by targeting delivery of methotrexate through glucan particles. Adv Healthc Mater. 2020;9:1901805.
   Google Scholar
• Soto ER, Ostroff GR. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug Chem. 2008;19:840–848.
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng H, Feng M, et al. Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy. Mol Ther Nucleic Acids. 2021;23:336–346.
   PubMedGoogle Scholar
• Kumar R, Kumar P. Yeast-based vaccines: new perspective in vaccine development and application. In: FEMS yeast research.  FEMS Yeast Res. 2019;19(2):foz007.
   Google Scholar
• Brückner S, Schubert R, Kraushaar T, et al. Kin discrimination in social yeast is mediated by cell surface receptors of the Flo11 adhesin family. eLife. 2020;9. DOI:10.7554/eLife.55587.
   PubMed Web of Science ®Google Scholar
• Walch-Rückheim B, Kiefer R, Geginat G, et al. Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigen-presenting cells. Gene Ther. 2016;23:103–107.
   PubMed Web of Science ®Google Scholar
• Childers DS, Avelar GM, Bain JM, et al. Epitope shaving promotes fungal immune evasion. mBio. 2020;11. DOI:10.1128/mBio.00984-20.
   PubMed Web of Science ®Google Scholar
• Zahradník J, Dey D, Marciano S, et al. An enhanced yeast display platform demonstrates the binding plasticity under various selection pressures. bioRxiv 2020.12.16.423176.
   Google Scholar
• Angrand G, Quillévéré A, Loaëc N, et al. Sneaking out for happy hour: yeast-based approaches to explore and modulate immune response and immune evasion. Genes (Basel). 2019;10:667.
   PubMed Web of Science ®Google Scholar
• Grover A, McLean JL, Troudt JM, et al. Heat killed Saccharomyces cerevisiae as an adjuvant for the induction of vaccine-mediated immunity against infection with Mycobacterium tuberculosis. Vaccine. 2016;34:2798–2805.
   PubMed Web of Science ®Google Scholar
• Hagert C, Siitonen R, Li XG, et al. Rapid spread of mannan to the immune system, skin and joints within 6 hours after local exposure. Clin Exp Immunol. 2019;196:383–391.
   PubMed Web of Science ®Google Scholar
• Choi JG, Dang Y, Abraham S, et al. Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Ther. 2016;23:627–633.
   PubMed Web of Science ®Google Scholar
• Chen Y, Song S, Yan Z, et al. Self-assembled rosette nanotubes encapsulate and slowly release dexamethasone. Int J Nanomedicine. 2011;6:1035–1044.
   PubMed Web of Science ®Google Scholar
• Gee P, Lung MSY, Okuzaki Y, et al. Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat Commun. 2020;11:1334.
   PubMed Web of Science ®Google Scholar
• Mangeot PE, Risson V, Fusil F, et al. Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat Commun. 2019;10:45.
   PubMed Web of Science ®Google Scholar
• Francesko A, Fernandes MM, Perelshtein I, et al. One-step sonochemical preparation of redox-responsive nanocapsules for glutathione mediated RNA release. J Mat Chem B. 2014;2:6020–6029.
   PubMed Web of Science ®Google Scholar
• Coradello G, Tirelli N. Yeast cells in microencapsulation. general features and controlling factors of the encapsulation process. Molecules. 2021;26:3123.
   PubMed Web of Science ®Google Scholar
• Petsch B, Schnee M, Vogel AB, et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol. 2012;30:1210–1216.
   PubMed Web of Science ®Google Scholar
• Bahl K, Senn JJ, Yuzhakov O, et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol Ther. 2017;25:1316–1327.
   PubMed Web of Science ®Google Scholar
• Brazzoli M, Magini D, Bonci A, et al. Induction of broad-based immunity and protective efficacy by self-amplifying mRNA vaccines encoding influenza virus hemagglutinin. J Virol. 2016;90:332–344.
   PubMed Web of Science ®Google Scholar
• Alberer M, Gnad-Vogt U, Hong HS, et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet. 2017;390:1511–1520.
   PubMed Web of Science ®Google Scholar
• Pei Y, Wong JHY, Robertson ES. Targeted therapies for epstein-barr virus-associated lymphomas. Cancers (Basel). 2020;12:2565.
   PubMed Web of Science ®Google Scholar
• Richner JM, Jagger BW, Shan C, et al. Vaccine mediated protection against zika virus-induced congenital disease. Cell. 2017;170:273–83.e12.
   PubMed Web of Science ®Google Scholar
• Jazayeri SD, Lim HX, Shameli K, et al. Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases. Front Pharmacol. 2021;12:682286.
   PubMed Web of Science ®Google Scholar
• Husseiny MI, Rawson J, Kaye A, et al. An oral vaccine for type 1 diabetes based on live attenuated Salmonella. Vaccine. 2014;32:2300–2307.
   PubMed Web of Science ®Google Scholar
• Le Moigne V, Gaillard J-L, Herrmann J-L. Vaccine strategies against cystic fibrosis pathogens. Hum Vaccin Immunother. 2016;12:751–756.
   PubMed Web of Science ®Google Scholar